Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

An adrenal incidentaloma is now established as a common endocrine diagnosis that
requires a multidisciplinary approach for effective management. The majority of patients can …

Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …

Pheochromocytomas and paragangliomas (PCC/PGLs) are rare, mostly catecholamine-
producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal …

Pheochromocytoma and paraganglioma (PPGL) require prompt consideration and efficient
diagnosis and treatment to minimize associated morbidity and mortality. Once considered …

BACKGROUND Measurements of plasma or urinary metanephrines are recommended for
diagnosis of pheochromocytoma and paraganglioma (PPGL). What test offers optimal …

BACKGROUND Pheochromocytomas and paragangliomas (PPGLs) are potentially lethal
yet usually surgically curable causes of endocrine hypertension; therefore, once clinical …

Pheochromocytomas (PHEOs) are rare neuroendocrine tumors that arise from the
chromaffin cells of the adrenal glands. Paragangliomas (PGLs), the extra-adrenal …

Pheochromocytomas are catecholamine producing neuroendocrine tumors that can be
adrenal or extra-adrenal in origin. The classic symptoms of pheochromocytoma are …

Purpose To determine the accuracy of biochemical tests for the diagnosis of
pheochromocytoma and paraganglioma. Methods A search of the PubMed database was …